Lizbeth C. Flores-Byrne, RN, NP
Nurse Practitioner · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Lizbeth C. Flores-Byrne’s office at (650) 498-6022 to ask if they take your plan before you enroll.
Drugs they prescribed that Part D paid
$3,511
Pharmacies billed $3,511 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
150 generic and fewer than 11 brand-name prescriptions · $3,511 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
Year by year
| 2024 | 152 | 22 | None | None | $3,511 |
| 2023 | 122 | 21 | None | None | $25,634 |
| 2022 | 136 | 21 | None | None | $19,937 |
| 2021 | 171 | 26 | None | 8% | $11,209 |
| 2020 | 216 | 23 | None | 25% | $330,940 |
| 2019 | 195 | 33 | None | None | $86,216 |
| 2018 | 194 | 50 | None | None | $12,882 |
| 2017 | 712 | 126 | 0% (0) | 30% | $124,914 |
| 2016 | 995 | 163 | 0% (0) | None | $176,963 |
| 2015 | 590 | 109 | 0% (0) | 22% | $93,293 |
| 2014 | 674 | 121 | 0% (0) | None | $93,840 |
| 2013 | 641 | 130 | None | 32% | $87,781 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2022: 1 drug
| Tacrolimus | 23 | $1,398 | $61 |
2021: 3 drugs
| Bumetanide | 22 | $2,007 | $91 |
| Amiodarone | 12 | $406 | $34 |
| Hydralazine | 13 | $138 | $11 |
2020: 2 drugs
| Bumetanide | 12 | $384 | $32 |
| Warfarin | 12 | $135 | $11 |
2019: 3 drugs
| Warfarin | 22 | $252 | $11 |
| Pantoprazole | 15 | $110 | $7 |
| Carvedilol | 11 | $50 | $5 |
2018: 4 drugs
| Gabapentin | 24 | $391 | $16 |
| Mirtazapine | 14 | $351 | $25 |
| Finasteride | 13 | $109 | $8 |
| Ranitidine | 11 | $68 | $6 |
2017: 21 drugs
| Linzess | 56 | $20,572 | $367 |
| Amitiza | 46 | $17,444 | $379 |
| Creon | 12 | $13,389 | $1,116 |
| Dexilant | 26 | $10,257 | $395 |
| Carafate | 18 | $5,632 | $313 |
| Ursodiol | 16 | $4,829 | $302 |
| Desipramine | 22 | $2,708 | $123 |
| Polyethylene Glycol 3350 | 16 | $1,390 | $87 |
| Proctosol-Hc | 12 | $1,261 | $105 |
| Gabapentin | 60 | $1,227 | $20 |
| Promethazine | 11 | $1,220 | $111 |
| Pyridostigmine | 12 | $623 | $52 |
| Mirtazapine | 23 | $588 | $26 |
| Pantoprazole | 40 | $574 | $14 |
| Ondansetron Odt | 18 | $541 | $30 |
| Baclofen | 27 | $513 | $19 |
| Dicyclomine | 30 | $432 | $14 |
| Buspirone | 13 | $237 | $18 |
| Nortriptyline | 19 | $216 | $11 |
| Ranitidine | 20 | $210 | $10 |
| Omeprazole | 33 | $175 | $5 |
2016: 26 drugs
| Creon | 24 | $26,403 | $1,100 |
| Linzess | 65 | $22,375 | $344 |
| Amitiza | 32 | $12,322 | $385 |
| Dexilant | 31 | $11,752 | $379 |
| Carafate | 20 | $6,602 | $330 |
| Granisetron | 14 | $3,686 | $263 |
| Desipramine | 38 | $2,994 | $79 |
| Ursodiol | 14 | $2,927 | $209 |
| Gabapentin | 112 | $2,655 | $24 |
| Trimethobenzamide | 22 | $2,558 | $116 |
| Proctosol-Hc | 13 | $1,457 | $112 |
| Lansoprazole | 27 | $1,144 | $42 |
| Dicyclomine | 67 | $1,018 | $15 |
| Pyridostigmine | 22 | $1,015 | $46 |
| Ondansetron Odt | 18 | $809 | $45 |
| Misoprostol | 13 | $769 | $59 |
| Omeprazole | 50 | $736 | $15 |
| Promethazine | 23 | $702 | $31 |
| Polyethylene Glycol 3350 | 18 | $698 | $39 |
| Mirtazapine | 34 | $695 | $20 |
| Baclofen | 28 | $665 | $24 |
| Buspirone | 28 | $619 | $22 |
| Ranitidine | 39 | $436 | $11 |
| Pantoprazole | 33 | $394 | $12 |
| Nortriptyline | 27 | $286 | $11 |
| Famotidine | 12 | $168 | $14 |
2015: 17 drugs
| Creon | 18 | $18,635 | $1,035 |
| Linzess | 31 | $9,459 | $305 |
| Amitiza | 21 | $9,027 | $430 |
| Octreotide Acetate | 18 | $4,571 | $254 |
| Ursodiol | 13 | $1,859 | $143 |
| Desipramine | 19 | $1,141 | $60 |
| Gabapentin | 71 | $1,105 | $16 |
| Ranitidine | 35 | $959 | $27 |
| Polyethylene Glycol 3350 | 14 | $770 | $55 |
| Dicyclomine | 62 | $678 | $11 |
| Omeprazole | 41 | $667 | $16 |
| Ondansetron Odt | 16 | $645 | $40 |
| Pantoprazole | 19 | $287 | $15 |
| Buspirone | 18 | $268 | $15 |
| Nortriptyline | 19 | $176 | $9 |
| Mirtazapine | 21 | $128 | $6 |
| Famotidine | 14 | $80 | $6 |
2014: 22 drugs
| Amitiza | 42 | $16,651 | $396 |
| Linzess | 35 | $10,519 | $301 |
| Octreotide Acetate | 15 | $7,775 | $518 |
| Nexium | 15 | $5,083 | $339 |
| Lyrica | 12 | $4,561 | $380 |
| Dexilant | 12 | $4,263 | $355 |
| Carafate | 16 | $2,087 | $130 |
| Gabapentin | 56 | $1,444 | $26 |
| Omeprazole | 54 | $1,161 | $22 |
| Dicyclomine | 65 | $918 | $14 |
| Polyethylene Glycol 3350 | 24 | $665 | $28 |
| Ondansetron Odt | 14 | $601 | $43 |
| Desipramine | 15 | $566 | $38 |
| Nortriptyline | 39 | $538 | $14 |
| Ondansetron | 14 | $481 | $34 |
| Pyridostigmine | 17 | $461 | $27 |
| Promethazine | 24 | $422 | $18 |
| Ranitidine | 26 | $394 | $15 |
| Pantoprazole | 17 | $363 | $21 |
| Bethanechol Chloride | 12 | $278 | $23 |
| Buspirone | 15 | $277 | $18 |
| Proctosol-Hc | 17 | $246 | $14 |
2013: 21 drugs
| Amitiza | 44 | $15,600 | $355 |
| Creon | 14 | $10,765 | $769 |
| Lyrica | 15 | $4,929 | $329 |
| Mestinon | 19 | $3,892 | $205 |
| Dexilant | 11 | $3,280 | $298 |
| Ursodiol | 18 | $2,010 | $112 |
| Gabapentin | 61 | $1,902 | $31 |
| Carafate | 11 | $1,317 | $120 |
| Transderm-Scop | 14 | $1,272 | $91 |
| Omeprazole | 38 | $944 | $25 |
| Pyridostigmine | 17 | $864 | $51 |
| Ondansetron | 16 | $854 | $53 |
| Ranitidine | 34 | $595 | $17 |
| Isosorbide Dinitrate | 12 | $582 | $49 |
| Pantoprazole | 24 | $473 | $20 |
| Nortriptyline | 32 | $462 | $14 |
| Dicyclomine | 26 | $386 | $15 |
| Azithromycin | 17 | $334 | $20 |
| Promethazine | 20 | $296 | $15 |
| Metoclopramide | 14 | $260 | $19 |
| Proctosol-Hc | 14 | $141 | $10 |
Money from drug and device companies
$2,296 in 2023
A payment is not proof that care is biased.
| Medtronic | Adapta | $2,296 | 19 payments
|
See all 19 published payments
| Medtronic | Meals · 2023-11-08 | None | $56 |
| Medtronic | Meals · 2023-11-08 | None | $59 |
| Medtronic | Meals · 2023-11-08 | None | $51 |
| Medtronic | Travel · 2023-11-08 | None | $20 |
| Medtronic | Travel · 2023-11-08 | None | $48 |
| Medtronic | Travel · 2023-11-07 | None | $279 |
| Medtronic | Travel · 2023-11-07 | None | $52 |
| Medtronic | Meals · 2023-11-07 | None | $61 |
| Medtronic | Meals · 2023-11-07 | None | $98 |
| Medtronic | Meals · 2023-11-07 | None | $168 |
| Medtronic | Meals · 2023-11-07 | None | $57 |
| Medtronic | Travel · 2023-11-06 | None | $278 |
| Medtronic | Travel · 2023-11-06 | None | $52 |
| Medtronic | Meals · 2023-11-06 | None | $211 |
| Medtronic | Travel · 2023-11-06 | None | $52 |
| Medtronic | Travel · 2023-10-20 | None | $714 |
| Medtronic | Education · 2023-04-01 | Adapta | $9 |
| Medtronic | Education · 2023-04-01 | None | $18 |
| Medtronic | Education · 2023-03-27 | None | $14 |
Professional record
- NPI
- 1366496945
- Licence
- CA NP10094
More record details
- Sole proprietor
- Yes
- Medicaid ID
- CA RN450588
- Taxonomy
- Nurse practitioner (363L00000X)
- Mailing address
- 300 Pasteur Dr, Palo Alto, CA, 94305
- NPI first listed
- 2006-05-19
- NPI last updated
- 2013-02-20
This is when the NPI record was last certified, not a medical board exam.